CA 125 Test Market Research Report - Global Forecast Till 2027

CA 125 Test Market Information: By Devices (Spectrometer, Analyzer, Sample Collection Tube, Otopic Labeled Peptides), Indication (Cancer, Uterine Fibroid, Endometriosis), By End User (Hospitals & Clinics, Diagnostic Centers) - Global Forecast till 2027

ID: MRFR/LS/3526-HCR | February 2021 | Region: Global | 110 pages

Please note that the assessment period of report has been updated from 2017-2023 to 2020-2027. Cordially fill the sample form for updated data.

 Market Synopsis of the Global CA 125 Test Market


Cancer Antigen (CA) test is used to diagnose various disease such as cancer, uterine fibroids, endometriosis, and liver disease. CA 125 is a protein that is found in the blood. The test is mostly widely used of the diagnosis of ovarian cancer in women. Normal levels of CA 125 in the blood is less 30 units per ml. and elevated levels for CA 125 signals the presence cancer in the ovary. Besides diagnosis, the CA 125 test is also used for monitoring ovarian cancer, as well as for screening ovarian cancer in women suspected to be at high risk for developing the disease.


Increasing demand for cancer diagnosis and treatment services, rising prevalence of cancer among the women and increasing emphasis on women healthcare. Furthermore, extensive diagnostic tests for cancer, also fuel the market growth. The growth of the market is restrained by the high cost of devices used in cancer diagnostics.


According to the American Cancer Society, in 2015, ovarian cancer represents only 3% of all malignancies in the U.S. women. Also there is a rise in the death rate due to various types of cancer of reproductive tract in women. Additionally, in the U.S., 22,280 women were estimated to have received an ovarian cancer diagnostic services and 14,240 deaths.


The global CA 125 test market is blooming and is expected to grow at a CAGR of 5.7% during the forecast period.


FIGURE 1: Global CA 125 test Market by Type, 2016 (%)
CA 125 Test Market
Source: World Health Organization, Centers for Disease Control and Prevention, European Society of Clinical Microbiology and Infectious Diseases, U.S. National Library of Medicine, National Organization for Rare Disorders, The International Society for Human and Animal Mycology, Expert Interview Market Research Future Analysis, Annual report, White paper, Company Presentation 


Intended Audience



  • Medical Device Manufacturers

  • Medical Device Suppliers

  • Medical Research Laboratories

  • Research and Development (R&D) Companies

  • Market Research and Consulting Service Providers

  • Potential Investors


Segments 


The global CA 125 test market is segmented on the basis of devices and accessories, devices, and end user.


On the basis of devices and accessories, market is segmented into spectrometer, analyzer, sample collection tubes, isotopic labeled peptides, and others.


On the basis of indication, the market is segmented into cancer, uterine fibroids, endometriosis, liver diseases, and others. Cancer is further segmented into ovarian cancer, endometrial cancer, fallopian tube cancer, stomach cancer, breast cancer, and others.


On the basis of end user, the market is segmented into hospitals & clinics, diagnostic centers, and others.
Key Players in the Global CA 125 Test Market 


Some of the key players in this market are Allergan plc. (U.K), Amgen Inc. (U.S.), Bayer (Germany), BD (U.S.), Eli Lilly Company (U.S.) , Merck & Co., Inc. (U.S.), Pfizer Inc. (U.S.), Teva Pharmaceuticals Private Limited (Israel), AMAG Pharmaceuticals (U.S.), Johnson & Johnson (U.S.), Sanofi (France), Novartis (Germany), AbbVie Inc. (U.S.), GlaxoSmithKline plc. (U.S.), and others.


Research Methodology


Global CA 125 Test Market
Source: World Health Organization, Centers for Disease Control and Prevention, European Society of Clinical Microbiology and Infectious Diseases, U.S. National Library of Medicine, National Organization for Rare Disorders, The American Autoimmune Related Diseases Association, The International Society for Human and Animal Mycology, Expert Interview Market Research Future Analysis, Annual report, White paper, Company Presentation


Regional Analysis of the Global CA 125 Test Market                


America holds the first position in the market for CA 125 test owing to the rising prevalence of ovarian cancer in the U.S. and Canada. Additionally, the availability of a wide range of diagnosis and treatment methods for cancer and technological advancement in the field of oncology, also support the growth of the market in American countries. Presence of key player in the market also accelerates the growth of the market. These players are engaged in various strategic approaches such as mergers, acquisition, collaborations, partnership, and research activities, leading to the development of the market in North America.


In Europe, the market shows extensive growth owing to extensive research and development activities, and increasing demand for new medical devices for diagnosis of cancer drive the growth of the market. Germany, U.K, and France acquire first, second and third place respectively, in the European CA 125 test market.


The market in Asia Pacific is expected to grow at the fastest pace whose market is driven rising awareness about reproductive health and diseases among women, and improving healthcare infrastructure. Availability of highly qualified healthcare professionals such as physicians, surgeons and gynecologist in the developing regions such as India, Japan and China further fuel the market.


The Middle East & Africa also show a steady rise in the market owing to low prevalence of ovarian cancer, rising demand for diagnostic services and growing emphasis on diagnosis and treatment of cancer disease. Developing healthcare infrastructure in the Middle East also fuels the growth of the market. In the Middle East & Africa, the Middle East accounts for the largest market share owing to the availability of better healthcare services in the Middle East countries than in Africa.



Frequently Asked Questions (FAQ) :


CA 125 test market CAGR 5.7% during the forecast period.

CA 125 test market would get boosted by growing demand for cancer diagnosis.

The devices and accessories mentioned in the CA 125 test market are analyzer, spectrometer, isotopic labeled peptides, sample collection tubes, and others.

CA 125 test market players are Bayer (Germany), Allergan plc. (U.K), Amgen Inc. (U.S.), Merck & Co., Inc. (U.S.), BD (U.S.), Eli Lilly Company (U.S.), Teva Pharmaceuticals Private Limited (Israel), Pfizer Inc. (U.S.), Johnson & Johnson (U.S.), Sanofi (France), AMAG Pharmaceuticals (U.S.), AbbVie Inc. (U.S.), GlaxoSmithKline plc. (U.S.), Novartis (Germany), and others.

The Americas would take charge of the CA 125 test market.

Table of Content

1. Report Prologue

2. Market Introduction

2.1 Definition

2.2 Scope of the Study

2.2.1 Research Objective

2.2.2 Assumptions

2.2.3 Limitations

3. Research Methodology

3.1 Introduction

3.2 Primary Research

3.3 Secondary research

3.4 Market Size Estimation

4. Market Dynamics

4.1 Drivers

4.2 Restrains

4.3 Opportunities

4.4 Challenges

4.5 Macroeconomic Indicators

4.6 Technology Trends & Assessment

5. Market Factor Analysis

5.1 Porters Five Forces Analysis

5.1.1 Bargaining Power of Suppliers

5.1.2 Bargaining Power of Buyers

5.1.3 Threat of New Entrants

5.1.4 Threat of Substitutes

5.1.5 Intensity of Rivalry

5.2 Value Chain Analysis

5.3 Investment Feasibility Analysis

5.4 Pricing Analysis

6. Global CA 125 test Market, by Device and Accessorie

6.1 Introduction

6.2 Spectrometer

6.2.1 Market Estimates & Forecast, 2020-2027

6.3 Analyzer

6.3.1 Market Estimates & Forecast, 2020-2027

6.4 Sample Collection Tubes

6.4.1 Market Estimates & Forecast, 2020-2027

6.5 Otopic Labeled Peptides

6.5.1 Market Estimates & Forecast, 2020-2027

6.6 Others

6.6.1 Market Estimates & Forecast, 2020-2027

7. Global CA 125 test Market, by Indication

7.1 Introduction

7.2 Cancer

7.2.1 Market Estimates & Forecast, 2020-2027

7.2.2 Ovarian cancer

7.2.3 Endometrial cancer

7.2.4 Fallopian tube cancer

7.2.5 Stomach cancer

7.2.6 Breast cancer

7.2.7 Others

7.3 Uterine fibroids

7.3.1 Market Estimates & Forecast, 2020-2027

7.4 Endometriosis

7.4.1 Market Estimates & Forecast, 2020-2027

7.5 Liver disease

7.5.1 Market Estimates & Forecast, 2020-2027

7.6 Others

7.6.1 Market Estimates & Forecast, 2020-2027

8. Global CA 125 test Market, by End User

8.1 Introduction

8.2 Hospitals & Clinics

8.2.1 Market Estimates & Forecast, 2020-2027

8.3 Diagnostic Centers

8.3.1 Market Estimates & Forecast, 2020-2027

9. Global CA 125 test Market, by Region

9.1 Introduction

9.2 Americas

9.2.1 North America

9.2.1.1 U.S.

9.2.1.1 Canada

9.2.2 South America

9.3 Europe

9.3.1 Western Europe

9.3.1.1 Germany

9.3.1.2 France

9.3.1.3 U.K

9.3.1.4 Italy

9.3.1.5 Spain

9.3.1.6 Rest of Western Europe

9.3.2 Eastern Europe

9.4 Asia Pacific

9.4.1 Japan

9.4.2 China

9.4.3 India

9.4.4 Australia

9.4.5 Republic of Korea

9.4.6 Rest of Asia Pacific

9.5 The Middle East & Africa

9.5.1 United Arab Emirates

9.5.2 Saudi Arabia

9.5.3 Oman

9.5.4 Kuwait

9.5.5 Qatar

9.5.6 Rest of the Middle East & Africa

10 Company Landscape

10.1 Introduction

10.2 Market Share Analysis

10.3 Key Development & Strategies

10.3.1 Key Developments

11 Company Profiles

11.1 Allergan plc.

11.1.1 Company Overview

11.1.2 Product Overview

11.1.3 Financials

11.1.4 SWOT Analysis

11.2 Bayer

11.2.1 Company Overview

11.2.2 Product Overview

11.2.3 Financial Overview

11.2.4 Key Developments

11.2.5 SWOT Analysis

11.3 BD

11.3.1 Company Overview

11.3.2 Product Overview

11.3.3 Financial Overview

11.3.4 Key Development

11.3.5 SWOT Analysis

11.4 Eli Lilly Company

11.4.1 Company Overview

11.4.2 Product/Business Segment Overview

11.4.3 Financial Overview

11.4.4 Key Development

11.4.5 SWOT Analysis

11.5 Merck & Co., Inc.

11.5.1 Company Overview

11.5.2 Product Overview

11.5.3 Financial overview

11.5.4 Key Developments

11.6 Pfizer Inc.

11.6.1 Overview

11.6.2 Product Overview

11.6.3 Financials

11.6.4 Key Developments

11.6.5 SWOT Analysis

11.7 Others

12 MRFR Conclusion

12.1 Key Findings

12.1.1 From CEO’s View Point

12.1.2 Unmet Needs of the Market

12.2 Key Companies to Watch

12.3 Prediction of Oncology Industry

13 Appendix

LIST OF TABLES

Table 1 CA 125 test Industry Synopsis, 2020-2027

Table 2 Global CA 125 test Market Estimates and Forecast, 2020-2027, (USD Million)

Table 3 Global CA 125 test Market by Region, 2020-2027, (USD Million)

Table 4 Global CA 125 test Market by Devices and Accessories, 2020-2027, (USD Million)

Table 5 Global CA 125 test Market by Indication, 2020-2027, (USD Million)

Table 6 Global CA 125 test Market by End Users, 2020-2027, (USD Million)

Table 7 North America CA 125 test Market by Devices and Accessories, 2020-2027, (USD Million)

Table 8 North America CA 125 test Market by Indication, 2020-2027, (USD Million)

Table 9 North America CA 125 test Market by End Users, 2020-2027, (USD Million)

Table 10 US CA 125 test Market by Devices and Accessories, 2020-2027, (USD Million)

Table 11 US CA 125 test Market by Indication, 2020-2027, (USD Million)

Table 12 US CA 125 test Market by End Users, 2020-2027, (USD Million)

Table 13 Canada CA 125 test Market by Devices and Accessories, 2020-2027, (USD Million)

Table 14 Canada CA 125 test Market by Indication, 2020-2027, (USD Million)

Table 15 Canada CA 125 test Market by End Users, 2020-2027, (USD Million)

Table 16 South America CA 125 test Market by Devices and Accessories, 2020-2027, (USD Million)

Table 17 South America CA 125 test Market by Indication, 2020-2027, (USD Million)

Table 18 South America CA 125 test Market by End Users, 2020-2027, (USD Million)

Table 19 Europe CA 125 test Market by Devices and Accessories, 2020-2027, (USD Million)

Table 20 Europe CA 125 test Market by Indication, 2020-2027, (USD Million)

Table 21 Europe CA 125 test Market by End Users, 2020-2027, (USD Million)

Table 22 Western Europe CA 125 test Market by Devices and Accessories, 2020-2027, (USD Million)

Table 23 Western Europe CA 125 test Market by Indication, 2020-2027, (USD Million)

Table 24 Western Europe CA 125 test Market by End Users, 2020-2027, (USD Million)

Table 25 Eastern Europe CA 125 test Market by Devices and Accessories, 2020-2027, (USD Million)

Table 26 Eastern Europe CA 125 test Market by Indication, 2020-2027, (USD Million)

Table 27 Eastern Europe CA 125 test Market by End Users, 2020-2027, (USD Million)

Table 28 Asia Pacific CA 125 test Market by Devices and Accessories, 2020-2027, (USD Million)

Table 29 Asia Pacific CA 125 test Market by Indication, 2020-2027, (USD Million)

Table 30 Asia Pacific CA 125 test Market by End Users, 2020-2027, (USD Million)

Table 31 Middle East & Africa CA 125 test Market by Devices and Accessories, 2020-2027, (USD Million)

Table 32 Middle East & Africa CA 125 test Market by Indication, 2020-2027, (USD Million)

Table 33 Middle East & Africa CA 125 test Market by End Users, 2020-2027, (USD Million)

LIST OF FIGURES

Figure 1 Research Process

Figure 2 Segmentation for Global CA 125 test Market

Figure 3 Segmentation Market Dynamics for CA 125 test Market

Figure 4 Global CA 125 test Market Share, by Devices and Accessories, 2020

Figure 5 Global CA 125 test Market Share, by Indication, 2020

Figure 6 Global CA 125 test Market Share, by End Users, 2020

Figure 7 Global CA 125 test Market Share, by Region, 2020

Figure 8 North America CA 125 test Market Share, by Country, 2020

Figure 9 Europe CA 125 test Market Share, by Country, 2020

Figure 10 Asia Pacific CA 125 test Market Share, by Country, 2020

Figure 11 Middle East & Africa CA 125 test Market Share, by Country, 2020

Figure 12 Global CA 125 test Market: Company Share Analysis, 2020 (%)

Figure 13 Allergan plc.: Key Financials

Figure 14 Allergan plc.: Segmental Revenue

Figure 16 Allergan plc: Geographical Revenue

Figure 17 Bayer: Key Financials

Figure 18 Bayer: Segmental Revenue

Figure 19 Bayer: Geographical Revenue

Figure 20 BD: Key Financials

Figure 21 BD: Segmental Revenue

Figure 22 BD: Geographical Revenue

Figure 23 Eli Lilly Company: Key Financials

Figure 24 Eli Lilly Company: Segmental Revenue

Figure 25 Eli Lilly Company: Geographical Revenue

Figure 26 Cynosure, Inc.: Key Financials

Figure 27 Cynosure, Inc.: Segmental Revenue

Figure 28 Cynosure, Inc.: Geographical Revenue

Figure 29 Merck & Co., Inc. : Key Financials

Figure 30 Merck & Co., Inc. : Segmental Revenue

Figure 31 Merck & Co., Inc. : Geographical Revenue

Figure 32 Pfizer Inc.: Key Financials

Figure 33 Pfizer Inc.: Segmental Revenue

Figure 34 Pfizer Inc.: Geographical Revenue